ArticleOncoTargets and therapy2022

miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1 [Expression of Concern].

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.